Switch to:
More From Other Websites
Chill Pill: Eli Lilly Cuts Guidance with Earnings Apr 25 2017
U.S. Supreme Court may limit where companies can be sued Apr 25 2017
3 Reasons Pfizer Is a Better Dividend Stock Than Bristol-Myers Squibb Apr 25 2017
America's 12 Most Charitable Companies Apr 25 2017
Transgene and Bristol-Myers Squibb Announce Clinical Research Collaboration to Evaluate TG4010 in... Apr 25 2017
NASH: The next untapped pharma market gives investors many options Apr 24 2017
3 Key Factors to Look Out for in Biogen's Q1 Results Apr 24 2017
Bristol-Myers Squibb’s BMS-986036 (Pegylated FGF21) Shows Consistent Improvement in Liver Fat,... Apr 22 2017
Bristol-Myers NASH drug reduces liver fat in midstage study Apr 22 2017
Bristol-Myers Squibb Receives Positive CHMP Opinion Recommending Approval of Opdivo (nivolumab) for... Apr 21 2017
Pharma Stock Roundup: J&J Slips on Mixed Q1, Lilly Hit by FDA CRL Apr 21 2017
Is Bristol-Myers Prepping To Outdo Itself In Immuno-Oncology? Apr 20 2017
Bristol-Myers Squibb Co: Buy the Dip? Apr 20 2017
Bristol-Myers 'Holding Up Better,' But Dow's Merck Still Gouging Share Apr 19 2017
The 4 Best Dividend Stocks in Pharmaceuticals Apr 18 2017
Bristol-Myers and Nordic Ink Biomarker Collaboration Deal Apr 18 2017
Exelixis, Inc.: Time to Move On? Apr 18 2017
Blog Coverage Bristol-Myers and Nordic Announce an Agreement for Development of Fibrosis Biomarker... Apr 18 2017
Top Research Reports for Alphabet, Amgen & Lowe's Apr 17 2017


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK